Daily metformin use in the month before pregnancy is associated with more than 70% reduction in risk for hyperemesis ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

In the early 2000s a clinical trial showed that lifestyle modification was better than metformin at preventing Type 2 ...

The study found that making changes in one's lifestyle lowered the development of diabetes by 24 per cent. The same on taking ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

Rapamycin may help prolong life as much as some dietary interventions, according to animal research. These findings, though, ...

A new study published in the American Journal of Obstetrics and Gynaecology revealed that for women with polycystic ovary ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

“Metformin is a widely used, first-line medication for treating type 2 diabetes.It belongs to a class of drugs called biguanides,” says Hans J. Schmidt, M.D., chief of bariatric surgery and ...